Targets, trafficking, and timing of cardiac autophagy

David Rotter, Beverly A. Rothermel

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Heart failure is the major case of death in developed countries, and its prevalence is growing worldwide. Autophagy is a fundamental cellular mechanism through which intracellular components can be removed, recycled and repaired. Studies in humans and animal models demonstrate a marked increase in cardiac autophagic activity under a wide range of disease states and in response to diverse stimuli. Recently, autophagy has been widely promoted as a potential therapeutic target for the treatment of cardiovascular disease and heart failure. An important challenge to achieving this goal is the dual nature of cardiac autophagy, sometimes acting to help preserve cardiac function, other times appearing to promote cardiac decline. Numerous control points regulating autophagic activity and cargo selection provide a diversity of opportunities for drug targeting. In addition there is an innate circadian rhythm to the systemic regulation of autophagy that is often overlooked but provides potential opportunities to target and optimize pharmacological intervention.

Original languageEnglish (US)
Pages (from-to)494-504
Number of pages11
JournalPharmacological Research
Volume66
Issue number6
DOIs
StatePublished - Dec 2012

Fingerprint

Autophagy
Heart Failure
Drug Delivery Systems
Circadian Rhythm
Developed Countries
Cardiovascular Diseases
Animal Models
Pharmacology
Therapeutics

Keywords

  • Autophagy
  • Cardiac
  • Cardiovascular disease
  • Circadian
  • Drug targets

ASJC Scopus subject areas

  • Pharmacology

Cite this

Targets, trafficking, and timing of cardiac autophagy. / Rotter, David; Rothermel, Beverly A.

In: Pharmacological Research, Vol. 66, No. 6, 12.2012, p. 494-504.

Research output: Contribution to journalArticle

@article{ea2e0771bd87460695c265e470b6f249,
title = "Targets, trafficking, and timing of cardiac autophagy",
abstract = "Heart failure is the major case of death in developed countries, and its prevalence is growing worldwide. Autophagy is a fundamental cellular mechanism through which intracellular components can be removed, recycled and repaired. Studies in humans and animal models demonstrate a marked increase in cardiac autophagic activity under a wide range of disease states and in response to diverse stimuli. Recently, autophagy has been widely promoted as a potential therapeutic target for the treatment of cardiovascular disease and heart failure. An important challenge to achieving this goal is the dual nature of cardiac autophagy, sometimes acting to help preserve cardiac function, other times appearing to promote cardiac decline. Numerous control points regulating autophagic activity and cargo selection provide a diversity of opportunities for drug targeting. In addition there is an innate circadian rhythm to the systemic regulation of autophagy that is often overlooked but provides potential opportunities to target and optimize pharmacological intervention.",
keywords = "Autophagy, Cardiac, Cardiovascular disease, Circadian, Drug targets",
author = "David Rotter and Rothermel, {Beverly A.}",
year = "2012",
month = "12",
doi = "10.1016/j.phrs.2012.10.001",
language = "English (US)",
volume = "66",
pages = "494--504",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press Inc.",
number = "6",

}

TY - JOUR

T1 - Targets, trafficking, and timing of cardiac autophagy

AU - Rotter, David

AU - Rothermel, Beverly A.

PY - 2012/12

Y1 - 2012/12

N2 - Heart failure is the major case of death in developed countries, and its prevalence is growing worldwide. Autophagy is a fundamental cellular mechanism through which intracellular components can be removed, recycled and repaired. Studies in humans and animal models demonstrate a marked increase in cardiac autophagic activity under a wide range of disease states and in response to diverse stimuli. Recently, autophagy has been widely promoted as a potential therapeutic target for the treatment of cardiovascular disease and heart failure. An important challenge to achieving this goal is the dual nature of cardiac autophagy, sometimes acting to help preserve cardiac function, other times appearing to promote cardiac decline. Numerous control points regulating autophagic activity and cargo selection provide a diversity of opportunities for drug targeting. In addition there is an innate circadian rhythm to the systemic regulation of autophagy that is often overlooked but provides potential opportunities to target and optimize pharmacological intervention.

AB - Heart failure is the major case of death in developed countries, and its prevalence is growing worldwide. Autophagy is a fundamental cellular mechanism through which intracellular components can be removed, recycled and repaired. Studies in humans and animal models demonstrate a marked increase in cardiac autophagic activity under a wide range of disease states and in response to diverse stimuli. Recently, autophagy has been widely promoted as a potential therapeutic target for the treatment of cardiovascular disease and heart failure. An important challenge to achieving this goal is the dual nature of cardiac autophagy, sometimes acting to help preserve cardiac function, other times appearing to promote cardiac decline. Numerous control points regulating autophagic activity and cargo selection provide a diversity of opportunities for drug targeting. In addition there is an innate circadian rhythm to the systemic regulation of autophagy that is often overlooked but provides potential opportunities to target and optimize pharmacological intervention.

KW - Autophagy

KW - Cardiac

KW - Cardiovascular disease

KW - Circadian

KW - Drug targets

UR - http://www.scopus.com/inward/record.url?scp=84869499324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869499324&partnerID=8YFLogxK

U2 - 10.1016/j.phrs.2012.10.001

DO - 10.1016/j.phrs.2012.10.001

M3 - Article

VL - 66

SP - 494

EP - 504

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

IS - 6

ER -